Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-02-26 @ 12:46 AM
Study NCT ID:
NCT03271151
Status:
COMPLETED
Last Update Posted:
2024-12-27
First Post:
2017-08-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty
Sponsor:
Hospital for Special Surgery, New York
Organization:
Study Overview
Official Title:
Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty: A Double-blinded Randomized Control Trial
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Post-discharge pain after total knee arthroplasty remains problematic; many patients have excessive pain at the 2 week time point (and often thereafter). Reduction in opioid use has become a national goal, due to the 'epidemic' in opioid misuse.
In addition to enrolling non-opioid users, we will enroll up to 15 chronic opioid users.
In addition to enrolling non-opioid users, we will enroll up to 15 chronic opioid users.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: